Raia Drogasil S.A.

São Paulo Stock Exchange RADL3.SA

Raia Drogasil S.A. Price to Earnings Ratio (P/E) on January 14, 2025: 27.32

Raia Drogasil S.A. Price to Earnings Ratio (P/E) is 27.32 on January 14, 2025, a -39.59% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Raia Drogasil S.A. 52-week high Price to Earnings Ratio (P/E) is 45.22 on January 15, 2024, which is 65.52% above the current Price to Earnings Ratio (P/E).
Raia Drogasil S.A. 52-week low Price to Earnings Ratio (P/E) is 26.71 on January 03, 2025, which is -2.23% below the current Price to Earnings Ratio (P/E).
Raia Drogasil S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is 38.73.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

São Paulo Stock Exchange: RADL3.SA

Raia Drogasil S.A.

CEO	Mr. Marcílio D'Amigo Pousada
IPO Date	Jan. 6, 2000
Location	Brazil
Headquarters	Av. Corifeu de Azevedo Marques, 3097
Employees	62,402
Sector	Health Care
Industries Drugstores & Retail Pharmacies Cosmetics Pharmaceuticals Specialty Retail

Description

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Key trends

Past 5 years